Regencell Bioscience Holdings Limited (RGC)

Home
RGC
Financials

5.4 (USD) • At close September 13, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2013	2012	2011	2010	2009	2007	2006	2005	2004	2002
Revenue Numbers are in millions	0	0	0	0	0	3,163	3,197.1	3,127.3	2,990.1	3,038.1	2,824.2	2,807.9	2,893.9	2,771	2,661	2,598	2,468	2,489	2,140
Cost of Revenue Numbers are in millions	0.77	0.604	0.026	0.01	0	123	1,226.8	1,207.5	111	111	101	101	1,157.1	106	103	104	94	92	84
Gross Profit Numbers are in millions	-0.77	-0.604	-0.026	-0.01	0	3,040	1,970.3	1,919.8	2,879.1	2,927.1	2,723.2	2,706.9	1,736.8	2,665	2,558	2,494	2,374	2,397	2,056
Gross Profit Ratio Numbers are in millions	0	0	0	0	0	0.961	0.616	0.614	0.963	0.963	0.964	0.964	0.6	0.962	0.961	0.96	0.962	0.963	0.961
Reseach & Development Expenses Numbers are in millions	1.582	2.512	0.438	0.386	0.228	0	0	0	0	0	0	0	0	0	0	0	0	0	0
General & Administrative Expenses Numbers are in millions	4.429	5.08	0.941	0.312	0.159	86.6	512.2	500.3	74.4	73.7	68.8	66.7	443	62	63	65	63	62	65
Selling & Marketing Expenses Numbers are in millions	0.263	0.025	0.002	0.114	0.004	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	4.692	5.106	0.943	0.426	0.163	86.6	512.2	500.3	74.4	73.7	68.8	66.7	443	62	63	65	63	62	65
Other Expenses Numbers are in millions	0.211	0.023	0.035	0	0	1,223.5	1,113.9	1,080.5	1,119.5	1,085.1	985.3	1,166.3	980.4	2,425	2,276	2,224	2,083	2,048	1,791
Operating Expenses Numbers are in millions	6.274	7.618	1.381	0.812	0.391	1,310.1	1,626.1	1,580.8	1,193.9	1,158.8	1,054.1	1,233	1,423.4	2,487	2,339	2,289	2,146	2,110	1,856
Operating Income Numbers are in millions	-6.274	-7.618	-1.381	-0.812	-0.391	271.7	344.2	339	306.4	339.8	334.2	215.8	313.4	284	322	308	321	379	283
Operating Income Ratio Numbers are in millions	0	0	0	0	0	0.086	0.108	0.108	0.102	0.112	0.118	0.077	0.108	0.102	0.121	0.119	0.13	0.152	0.132
Total Other Income Expenses Net Numbers are in millions	0.211	0.023	0.035	-0	0	-57.8	-62.5	-85.7	-127.8	-75.2	-98.3	-140.1	-156.2	-161	283	-164	-179	-73	-75
Income Before Tax Numbers are in millions	-6.062	-7.595	-1.347	-0.812	-0.391	213.9	281.7	253.3	178.6	264.6	235.9	75.7	157.2	123	605	144	142	306	208
Income Before Tax Ratio Numbers are in millions	0	0	0	0	0	0.068	0.088	0.081	0.06	0.087	0.084	0.027	0.054	0.044	0.227	0.055	0.058	0.123	0.097
Income Tax Expense Numbers are in millions	-0.191	-0.172	-0.21	-0	-0	101.6	111.2	100.1	73.4	107	91.2	48.7	61.9	50	242	57	59	121	89
Net Income Numbers are in millions	-5.871	-7.423	-1.347	-0.812	-0.391	112.3	170.4	153.4	105.6	157.7	144.8	77.6	95.5	72	363	86	82	185	117
Net Income Ratio Numbers are in millions	0	0	0	0	0	0.036	0.053	0.049	0.035	0.052	0.051	0.028	0.033	0.026	0.136	0.033	0.033	0.074	0.055
EPS Numbers are in millions	-0.45	-0.57	-0.11	-0.064	-0.031	0.72	1.09	0.98	0.68	1.02	0.94	0.51	0.62	62.1	63.1	65.9	0.57	1.34	0.83
EPS Diluted Numbers are in millions	-0.45	-0.57	-0.11	-0.064	-0.031	0.72	1.09	0.98	0.68	1.01	0.93	0.5	0.62	62.1	63.1	65.9	0.55	1.3	0.79
EBITDA Numbers are in millions	-5.504	-7.013	-1.355	-0.803	-0.391	468.7	512.3	470.3	391	469.2	422.2	352.5	512.1	200	676	215	220	392	401
EBITDA Ratio Numbers are in millions	0	0	0	0	0	0.148	0.16	0.15	0.131	0.154	0.149	0.126	0.177	0.072	0.254	0.083	0.089	0.157	0.187

Regencell Bioscience Holdings Limited

NASDAQ:RGC Add to watchlist

NASDAQ:RGC